Sensex, Nifty trade flat; IT, metals, pharma stocks gain

Sun Pharma to acquire Ranbaxy in $4 billion all-stock deal
Sun Pharma to acquire Ranbaxy in $4 billion all-stock deal

Equity benchmarks continued to trade around flatline in afternoon due to lack of domestic and global cues, but the broader markets continued their outperformance.

The 30-share BSE Sensex was down 4.89 points at 33,772.49 and the 50-share NSE Nifty gained 3.50 points at 10,447.70 while the Nifty Midcap extended gains to 0.9 percent.

About two shares advanced for every share falling on the BSE.

For more information ✆ – 0731-6642300 or visit- http://www.epicresearch.co/festive-offers

Facebook Twitter YouTube Pinterest Linkedin Google+

You may also like:

Sensex, Nifty rangebound; RBI’s MPC meet outcome awaited' width= Sensex, Nifty continue to be sluggish ahead of RBI policy; Europe mixed' width=
Sensex, Nifty rangebound; RBI’s MPC meet outcome awaited Sensex, Nifty continue to be sluggish ahead of RBI policy; Europe mixed
Share Button

About the Author

Epic Research
Epic Research
Epic Research - Investment Adviser is a leading financial services provider with presence in Indian and other global capital markets. Call on - 0731-664-2300